SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 52 filers reported holding SAGE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $272,664,000 | -57.4% | 6,442,916 | -26.6% | 25.46% | -61.8% |
Q2 2015 | $640,434,000 | +30.5% | 8,773,073 | -10.2% | 66.66% | +27.3% |
Q1 2015 | $490,901,000 | +14.8% | 9,773,073 | -16.3% | 52.36% | +49.7% |
Q4 2014 | $427,525,000 | +16.2% | 11,681,008 | 0.0% | 34.96% | -18.5% |
Q3 2014 | $367,952,000 | – | 11,681,008 | – | 42.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 357,765 | $16,822,110 | 5.82% |
Palo Alto Investors LP | 859,517 | $40,414,489 | 3.26% |
Boxer Capital, LLC | 1,094,000 | $51,440 | 2.39% |
DAFNA Capital Management LLC | 180,306 | $8,477,988 | 2.32% |
Bellevue Group AG | 3,114,375 | $146,437,913 | 2.09% |
Saturn V Capital Management LP | 70,559 | $3,317,684 | 1.84% |
SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $6,018,560 | 0.94% |
Artal Group S.A. | 500,000 | $23,510 | 0.73% |
Parkman Healthcare Partners LLC | 70,033 | $3,292,952 | 0.57% |
Integral Health Asset Management, LLC | 80,000 | $3,761,600 | 0.47% |